DekaBank Deutsche Girozentrale Sells 83,000 Shares of Enhabit, Inc. (NYSE:EHAB)

DekaBank Deutsche Girozentrale lowered its position in shares of Enhabit, Inc. (NYSE:EHAB - Free Report) by 19.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 340,412 shares of the company's stock after selling 83,000 shares during the quarter. DekaBank Deutsche Girozentrale owned 0.67% of Enhabit worth $2,905,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GAMMA Investing LLC boosted its holdings in shares of Enhabit by 295.2% in the 1st quarter. GAMMA Investing LLC now owns 3,533 shares of the company's stock valued at $31,000 after buying an additional 2,639 shares during the last quarter. Quantbot Technologies LP acquired a new stake in shares of Enhabit in the 4th quarter valued at approximately $45,000. Group One Trading LLC boosted its holdings in shares of Enhabit by 248.3% in the 4th quarter. Group One Trading LLC now owns 7,746 shares of the company's stock valued at $60,000 after buying an additional 5,522 shares during the last quarter. Corient Private Wealth LLC acquired a new stake in shares of Enhabit in the 4th quarter valued at approximately $79,000. Finally, Quarry LP boosted its holdings in shares of Enhabit by 692.6% in the 4th quarter. Quarry LP now owns 10,811 shares of the company's stock valued at $84,000 after buying an additional 9,447 shares during the last quarter.

Enhabit Stock Down 1.8%

Shares of NYSE EHAB traded down $0.13 during trading hours on Monday, hitting $6.93. The company had a trading volume of 244,081 shares, compared to its average volume of 482,145. The stock has a market capitalization of $350.66 million, a P/E ratio of -2.50 and a beta of 1.72. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.82. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $10.91. The firm's 50 day moving average is $9.54 and its 200-day moving average is $8.68.

Enhabit (NYSE:EHAB - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. The company had revenue of $259.90 million during the quarter, compared to the consensus estimate of $266.11 million. Enhabit had a positive return on equity of 2.02% and a negative net margin of 13.43%. On average, analysts expect that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.